CRITICAL VIEW ON NEOADJUVANT CHEMOTHERAPY FOLLOWED BY FERTILITY-SPARING SURGERY. EXPERIENCES WITH 25 PATIENTS

被引：0
|
作者：
Robova, H. [1 ,2 ]
Rob, L. [1 ,2 ]
Halaska, M. J. [1 ,2 ]
Komar, M. [1 ,2 ]
Pluta, M. [1 ,2 ]
Skapa, P. [1 ,2 ]
机构：
[1] Charles Univ Prague, Fac Med 2, Prague, Czech Republic
[2] Univ Hosp Motol, Prague, Czech Republic
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2013年 / 23卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Ovarian function, fertility, and menopause occurrence after fertility-sparing surgery and chemotherapy for ovarian neoplasms
    Ceppi, Lorenzo
    Galli, Francesca
    Lamanna, Maria
    Magni, Sonia
    Dell'Orto, Federica
    Verri, Debora
    Delle Marchette, Martina
    Lissoni, Andrea Alberto
    Sina, Federica
    Giuliani, Daniela
    Grassi, Tommaso
    Landoni, Fabio
    Bonazzi, Cristina Maria
    Fruscio, Robert
    GYNECOLOGIC ONCOLOGY, 2019, 152 (02) : 346 - 352
  • [22] FERTILITY-SPARING SURGERY IN PATIENTS WITH BORDERLINE OVARIAN TUMORS AND REPRODUCTIVE OUTCOMES
    Helmut, P.
    Harter, P.
    Ataseven, B.
    Heitz, F.
    Prader, S.
    Schneider, S.
    Heikaus, S.
    Traut, A.
    du Bois, A.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A47 - A48
  • [23] How many ovarian cancer patients are eligible for fertility-sparing surgery?
    Huber, D.
    Cimorelli, V.
    Usel, M.
    Bouchardy, C.
    Rapiti, E.
    Petignat, P.
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2013, 170 (01) : 270 - 274
  • [24] FERTILITY-SPARING SURGERY (FSS) IN PATIENTS WITH BORDERLINE OVARIAN TUMORS (BOT)
    Vdovichenko, N.
    Harter, P.
    Ataseven, B.
    Heitz, F.
    Prader, S.
    Schneider, S.
    Kurzeder, K.
    Heikaus, S.
    Weikel, W.
    Fisseler-Eckhoff, A.
    Traut, A.
    du Bois, A.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2015, 25 (09) : 1568 - 1568
  • [25] Fertility-sparing surgery for young patients with sarcoma involving the uterine cervix
    Wu, X.
    Li, J.
    GYNECOLOGIC ONCOLOGY, 2017, 145 : 218 - 219
  • [26] Fertility-sparing surgery (FSS) in patients with borderline ovarian tumors (BOT)
    Vdovichenko, N.
    Ataseven, B.
    Heitz, F.
    Prader, S.
    Schneider, S.
    Kurzeder, C.
    Heikaus, S.
    Weikel, W.
    Fisseler-Eckhoff, A.
    Alexander, T.
    du Bois, A.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 92 - 92
  • [27] Survival of selected patients with ovarian cancer treated with fertility-sparing surgery
    Hedback, Nora Elisabeth
    Karlsen, Mona Aarenstrup
    Hogdall, Claus Kim
    Rosendahl, Mikkel
    REPRODUCTIVE BIOMEDICINE ONLINE, 2018, 37 (01) : 71 - 76
  • [28] CONTESSA/NEOCON-F TRIAL: ASSESSING THE EFFECTIVENESS AND SAFETY OF NEOADJUVANT CHEMOTHERAPY FOLLOWED BY FERTILITY-SPARING SURGERY IN FIGO 2018 STAGE IB2 CERVICAL CANCER
    Plante, Marie
    van Trommel, Nenke E.
    Schaafsma, Mirte
    Oza, Amit M.
    Rodriguez, Angela
    Wang, Lisa
    Sikorska, Karolina
    Ferguson, Sarah E.
    Han, Kathy
    Lheureux, Stephanie
    Amant, Frederic
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2022, 32 : A20 - A20
  • [29] Neoadjuvant chemotherapy in fertility-sparing management of FIGO 2018 stage IB2 cervical cancer
    Sanson, Claire
    Zaccarini, Francois
    Majer, Michael
    Pautier, Patricia
    Genestie, Catherine
    Chargari, Cyrus
    Gouy, Sebastien
    Morice, Philippe
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2022, 32 (05) : 680 - 685
  • [30] Neoadjuvant Chemotherapy Prior Fertility-Sparing Surgery in Women with FIGO 2018 Stage IB2 Cervical Cancer: A Systematic Review
    Buda, Alessandro
    Borghese, Martina
    Puppo, Andrea
    Perotto, Stefania
    Novelli, Antonia
    Borghi, Chiara
    Olearo, Elena
    Tripodi, Elisa
    Surace, Alessandra
    Bar, Enrica
    Scambia, Giovanni
    Fanfani, Francesco
    CANCERS, 2022, 14 (03)
12345